PDB Short entry for 1IQF HEADER HYDROLASE 23-JUL-01 1IQF TITLE HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55165 COMPND MOL_ID: 1; COMPND 2 MOLECULE: COAGULATION FACTOR XA; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: HEAVY CHAIN, CATALYTIC DOMAIN (RESIDUES 235-469); COMPND 5 EC: 3.4.21.6; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: COAGULATION FACTOR XA; COMPND 8 CHAIN: L; COMPND 9 FRAGMENT: LIGHT CHAIN, EPIDERMAL GROWTH FACTOR LIKE DOMAIN (RESIDUES COMPND 10 84-179); COMPND 11 EC: 3.4.21.6 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 MOL_ID: 2; SOURCE 6 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 7 ORGANISM_COMMON: HUMAN; SOURCE 8 ORGANISM_TAXID: 9606 KEYWDS HYDROLASE, SERINE PROTEASE, BLOOD COAGULATION FACTOR, COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR I.SHIROMIZU,T.MATSUSUE REVDAT 5 27-DEC-23 1IQF 1 REMARK REVDAT 4 04-OCT-17 1IQF 1 REMARK REVDAT 3 24-FEB-09 1IQF 1 VERSN REVDAT 2 27-NOV-07 1IQF 1 TITLE REVDAT 1 23-SEP-03 1IQF 0 JRNL AUTH T.MATSUSUE,I.SHIROMIZU,A.OKAMOTO,K.NAKAYAMA,H.NISHIDA, JRNL AUTH 2 T.MUKAIHIRA,Y.MIYAZAKI,F.SAITOU,H.MORISHITA,S.OHNISHI, JRNL AUTH 3 H.MOCHIZUKI JRNL TITL FACTOR XA SPECIFIC INHIBITOR THAT INDUCES THE NOVEL BINDING JRNL TITL 2 MODEL IN COMPLEX WITH HUMAN FXA JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH K.PADMANABHAN,K.P.PADMANABHAN,A.TULINSKY,C.H.PARK,W.BODE, REMARK 1 AUTH 2 R.HUBER,D.T.BLANKENSHIP,A.D.CARDIN,W.KISIEL REMARK 1 TITL STRUCTURE OF HUMAN DES(1-45) FACTOR XA AT 2.2 A RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 232 947 1993 REMARK 1 REFN ISSN 0022-2836 REMARK 1 DOI 10.1006/JMBI.1993.1441 REMARK 1 REFERENCE 2 REMARK 1 AUTH H.BRANDSTETTER,A.KUHNE,W.BODE,R.HUBER,W.VON DER SAAL, REMARK 1 AUTH 2 K.WIRTHENSOHN,R.A.ENGH REMARK 1 TITL X-RAY STRUCTURE OF ACTIVE SITE-INHIBITED CLOTTING FACTOR XA. REMARK 1 TITL 2 IMPLICATIONS FOR DRUG DESIGN AND SUBSTRATE RECOGNITION REMARK 1 REF J.BIOL.CHEM. V. 271 29988 1996 REMARK 1 REFN ISSN 0021-9258 REMARK 1 DOI 10.1074/JBC.271.47.29988 REMARK 1 REFERENCE 3 REMARK 1 AUTH E.L.PRYZDIAL,G.E.KESSLER REMARK 1 TITL AUTOPROTEOLYSIS OR PLASMIN-MEDIATED CLEAVAGE OF FACTOR REMARK 1 TITL 2 XAALPHA EXPOSES A PLASMINOGEN BINDING SITE AND INHIBITS REMARK 1 TITL 3 COAGULATION REMARK 1 REF J.BIOL.CHEM. V. 271 16614 1996 REMARK 1 REFN ISSN 0021-9258 REMARK 1 DOI 10.1074/JBC.271.28.16614 REMARK 2 REMARK 2 RESOLUTION. 3.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2000 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 8063.560 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 81.0 REMARK 3 NUMBER OF REFLECTIONS : 4235 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.169 REMARK 3 R VALUE (WORKING SET) : 0.169 REMARK 3 FREE R VALUE : 0.277 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.600 REMARK 3 FREE R VALUE TEST SET COUNT : 449 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.013 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.39 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 69.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 529 REMARK 3 BIN R VALUE (WORKING SET) : 0.1880 REMARK 3 BIN FREE R VALUE : 0.3180 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 64 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.040 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2239 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 12.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM SIGMAA (A) : 0.24 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.46 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.49 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.890 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.270 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.760 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.940 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.620 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 48.28 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : ION.PARAM REMARK 3 PARAMETER FILE 3 : PARM65.PRO REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : ION.TOP REMARK 3 TOPOLOGY FILE 3 : TOPM65.PRO REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1IQF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 30-JUL-01. REMARK 100 THE DEPOSITION ID IS D_1000005179. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-FEB-99 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : YALE MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : R-AXIS REMARK 200 DATA SCALING SOFTWARE : R-AXIS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 4578 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.200 REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 80.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.05300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.30 REMARK 200 COMPLETENESS FOR SHELL (%) : 66.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.07100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: GLRF REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.79 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG1500, CALCIUM CHLORIDE, M55165, REMARK 280 TRIS-HCL, PH 7.2, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.14500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 28.31500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.02000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 28.31500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.14500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.02000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 TYR L 44 REMARK 465 LYS L 45 REMARK 465 ASP L 46 REMARK 465 GLY L 47 REMARK 465 ASP L 48 REMARK 465 GLN L 49 REMARK 465 CYS L 50 REMARK 465 GLU L 51 REMARK 465 THR L 52 REMARK 465 SER L 53 REMARK 465 PRO L 54 REMARK 465 CYS L 55 REMARK 465 GLN L 56 REMARK 465 ASN L 57 REMARK 465 GLN L 58 REMARK 465 GLY L 59 REMARK 465 LYS L 60 REMARK 465 CYS L 61 REMARK 465 LYS L 62 REMARK 465 ASP L 63 REMARK 465 GLY L 64 REMARK 465 LEU L 65 REMARK 465 GLY L 66 REMARK 465 GLU L 67 REMARK 465 TYR L 68 REMARK 465 THR L 69 REMARK 465 CYS L 70 REMARK 465 THR L 71 REMARK 465 CYS L 72 REMARK 465 LEU L 73 REMARK 465 GLU L 74 REMARK 465 GLY L 75 REMARK 465 PHE L 76 REMARK 465 GLU L 77 REMARK 465 GLY L 78 REMARK 465 LYS L 79 REMARK 465 ASN L 80 REMARK 465 CYS L 81 REMARK 465 GLU L 82 REMARK 465 LEU L 83 REMARK 465 PHE L 84 REMARK 465 THR L 85 REMARK 465 ARG L 86 REMARK 465 GLU L 138 REMARK 465 ARG L 139 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 22 93.94 -58.62 REMARK 500 PRO A 28 -12.96 -48.78 REMARK 500 GLN A 30 99.48 -59.90 REMARK 500 ASN A 38 11.50 52.70 REMARK 500 LEU A 59 34.83 -74.44 REMARK 500 TYR A 60 -32.71 -132.65 REMARK 500 GLN A 61 26.85 -77.93 REMARK 500 THR A 73 55.05 -90.16 REMARK 500 GLU A 74 6.01 176.95 REMARK 500 GLU A 80 -170.81 -59.00 REMARK 500 ALA A 81 142.17 174.45 REMARK 500 ASN A 92 -75.00 -24.26 REMARK 500 ARG A 93 17.94 -55.41 REMARK 500 THR A 95 113.00 -164.37 REMARK 500 PHE A 101 47.54 73.51 REMARK 500 ARG A 115 -155.16 -115.82 REMARK 500 ASN A 117 4.30 57.63 REMARK 500 ARG A 125 -82.27 -36.27 REMARK 500 HIS A 145 148.27 175.46 REMARK 500 SER A 172 -177.22 -56.40 REMARK 500 THR A 177 -169.25 -77.36 REMARK 500 PHE A 181 132.57 -170.23 REMARK 500 ALA A 183 129.85 -172.48 REMARK 500 THR A 185B -23.65 -146.95 REMARK 500 GLN A 187 47.07 -71.22 REMARK 500 ASP A 189 151.67 171.66 REMARK 500 ALA A 190 174.71 -59.51 REMARK 500 CYS A 191 -158.10 -160.47 REMARK 500 SER A 214 -73.61 -95.88 REMARK 500 LYS A 230 97.20 -65.40 REMARK 500 THR A 232 -8.92 -57.64 REMARK 500 LEU A 235 -76.89 -39.13 REMARK 500 THR A 244 122.86 71.88 REMARK 500 CYS L 89 30.67 -72.81 REMARK 500 ASP L 92 52.52 -160.81 REMARK 500 GLN L 98 -133.74 -140.68 REMARK 500 PHE L 99 125.58 -37.97 REMARK 500 GLN L 104 -35.12 55.36 REMARK 500 THR L 136 95.69 -61.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 301 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU A 77 OE1 REMARK 620 2 GLU A 80 OE1 60.2 REMARK 620 N 1 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE XMD A 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1IOE RELATED DB: PDB REMARK 900 1IOE CONTAINS THE SAME PROTEIN COMPLEXED WITH M55532 REMARK 900 RELATED ID: 1IQE RELATED DB: PDB REMARK 900 1IQE CONTAINS THE SAME PROTEIN COMPLEXED WITH M55590 REMARK 900 RELATED ID: 1IQG RELATED DB: PDB REMARK 900 1IQG CONTAINS THE SAME PROTEIN COMPLEXED WITH M55159 REMARK 900 RELATED ID: 1IQH RELATED DB: PDB REMARK 900 1IQH CONTAINS THE SAME PROTEIN COMPLEXED WITH M55143 REMARK 900 RELATED ID: 1IQI RELATED DB: PDB REMARK 900 1IQI CONTAINS THE SAME PROTEIN COMPLEXED WITH M55125 REMARK 900 RELATED ID: 1IQJ RELATED DB: PDB REMARK 900 1IQJ CONTAINS THE SAME PROTEIN COMPLEXED WITH M55124 REMARK 900 RELATED ID: 1IQK RELATED DB: PDB REMARK 900 1IQK CONTAINS THE SAME PROTEIN COMPLEXED WITH M55113 REMARK 900 RELATED ID: 1IQL RELATED DB: PDB REMARK 900 1IQL CONTAINS THE SAME PROTEIN COMPLEXED WITH M54476 REMARK 900 RELATED ID: 1IQM RELATED DB: PDB REMARK 900 1IQM CONTAINS THE SAME PROTEIN COMPLEXED WITH M54471 REMARK 900 RELATED ID: 1IQN RELATED DB: PDB REMARK 900 1IQN CONTAINS THE SAME PROTEIN COMPLEXED WITH M55192 DBREF 1IQF A 16 245 UNP P00742 FA10_HUMAN 235 469 DBREF 1IQF L 44 139 UNP P00742 FA10_HUMAN 84 179 SEQRES 1 A 235 ILE VAL GLY GLY GLN GLU CYS LYS ASP GLY GLU CYS PRO SEQRES 2 A 235 TRP GLN ALA LEU LEU ILE ASN GLU GLU ASN GLU GLY PHE SEQRES 3 A 235 CYS GLY GLY THR ILE LEU SER GLU PHE TYR ILE LEU THR SEQRES 4 A 235 ALA ALA HIS CYS LEU TYR GLN ALA LYS ARG PHE LYS VAL SEQRES 5 A 235 ARG VAL GLY ASP ARG ASN THR GLU GLN GLU GLU GLY GLY SEQRES 6 A 235 GLU ALA VAL HIS GLU VAL GLU VAL VAL ILE LYS HIS ASN SEQRES 7 A 235 ARG PHE THR LYS GLU THR TYR ASP PHE ASP ILE ALA VAL SEQRES 8 A 235 LEU ARG LEU LYS THR PRO ILE THR PHE ARG MET ASN VAL SEQRES 9 A 235 ALA PRO ALA CYS LEU PRO GLU ARG ASP TRP ALA GLU SER SEQRES 10 A 235 THR LEU MET THR GLN LYS THR GLY ILE VAL SER GLY PHE SEQRES 11 A 235 GLY ARG THR HIS GLU LYS GLY ARG GLN SER THR ARG LEU SEQRES 12 A 235 LYS MET LEU GLU VAL PRO TYR VAL ASP ARG ASN SER CYS SEQRES 13 A 235 LYS LEU SER SER SER PHE ILE ILE THR GLN ASN MET PHE SEQRES 14 A 235 CYS ALA GLY TYR ASP THR LYS GLN GLU ASP ALA CYS GLN SEQRES 15 A 235 GLY ASP SER GLY GLY PRO HIS VAL THR ARG PHE LYS ASP SEQRES 16 A 235 THR TYR PHE VAL THR GLY ILE VAL SER TRP GLY GLU GLY SEQRES 17 A 235 CYS ALA ARG LYS GLY LYS TYR GLY ILE TYR THR LYS VAL SEQRES 18 A 235 THR ALA PHE LEU LYS TRP ILE ASP ARG SER MET LYS THR SEQRES 19 A 235 ARG SEQRES 1 L 96 TYR LYS ASP GLY ASP GLN CYS GLU THR SER PRO CYS GLN SEQRES 2 L 96 ASN GLN GLY LYS CYS LYS ASP GLY LEU GLY GLU TYR THR SEQRES 3 L 96 CYS THR CYS LEU GLU GLY PHE GLU GLY LYS ASN CYS GLU SEQRES 4 L 96 LEU PHE THR ARG LYS LEU CYS SER LEU ASP ASN GLY ASP SEQRES 5 L 96 CYS ASP GLN PHE CYS HIS GLU GLU GLN ASN SER VAL VAL SEQRES 6 L 96 CYS SER CYS ALA ARG GLY TYR THR LEU ALA ASP ASN GLY SEQRES 7 L 96 LYS ALA CYS ILE PRO THR GLY PRO TYR PRO CYS GLY LYS SEQRES 8 L 96 GLN THR LEU GLU ARG HET CA A 301 1 HET XMD A 401 39 HETNAM CA CALCIUM ION HETNAM XMD (2R)-4-[(6-CHLORO-2-NAPHTHALENYL)SULFONYL]-6-OXO-1-[[1- HETNAM 2 XMD (4-PYRIDINYL)-4-PIPERIDINYL]METHYL]-2- HETNAM 3 XMD PIPERAZINECARBOXYLIC ACID ETHYL ESTER FORMUL 3 CA CA 2+ FORMUL 4 XMD C28 H31 CL N4 O5 S HELIX 1 1 ALA A 55 LEU A 59 5 5 HELIX 2 2 GLU A 124A LEU A 131A 1 9 HELIX 3 3 ASP A 164 SER A 172 1 9 HELIX 4 4 PHE A 234 LYS A 243 1 10 HELIX 5 5 ASP L 92 CYS L 96 5 5 SHEET 1 A 7 GLN A 20 GLU A 21 0 SHEET 2 A 7 LYS A 156 PRO A 161 -1 O MET A 157 N GLN A 20 SHEET 3 A 7 THR A 135 GLY A 140 -1 N GLY A 136 O VAL A 160 SHEET 4 A 7 PRO A 198 ARG A 202 -1 O PRO A 198 N SER A 139 SHEET 5 A 7 TYR A 207 GLY A 216 -1 N PHE A 208 O THR A 201 SHEET 6 A 7 GLY A 226 LYS A 230 -1 O ILE A 227 N TRP A 215 SHEET 7 A 7 MET A 180 ALA A 183 -1 O PHE A 181 N TYR A 228 SHEET 1 B 6 PHE A 64 ARG A 67 0 SHEET 2 B 6 GLN A 30 ASN A 35 -1 O LEU A 32 N ARG A 67 SHEET 3 B 6 GLY A 40 ILE A 46 -1 N PHE A 41 O LEU A 33 SHEET 4 B 6 TYR A 51 THR A 54 -1 N LEU A 53 O THR A 45 SHEET 5 B 6 ALA A 104 LEU A 108 -1 O ALA A 104 N THR A 54 SHEET 6 B 6 VAL A 85 LYS A 90 -1 N GLU A 86 O ARG A 107 SHEET 1 C 2 GLU L 102 GLU L 103 0 SHEET 2 C 2 SER L 106 VAL L 107 -1 O SER L 106 N GLU L 103 SHEET 1 D 2 TYR L 115 LEU L 117 0 SHEET 2 D 2 CYS L 124 PRO L 126 -1 N ILE L 125 O THR L 116 SSBOND 1 CYS A 22 CYS A 27 1555 1555 2.03 SSBOND 2 CYS A 42 CYS A 58 1555 1555 2.03 SSBOND 3 CYS A 122 CYS L 132 1555 1555 2.04 SSBOND 4 CYS A 168 CYS A 182 1555 1555 2.01 SSBOND 5 CYS A 191 CYS A 220 1555 1555 2.03 SSBOND 6 CYS L 89 CYS L 100 1555 1555 2.03 SSBOND 7 CYS L 96 CYS L 109 1555 1555 2.03 SSBOND 8 CYS L 111 CYS L 124 1555 1555 2.02 LINK OE1 GLU A 77 CA CA A 301 1555 1555 2.83 LINK OE1 GLU A 80 CA CA A 301 1555 1555 2.83 SITE 1 AC1 5 ASP A 70 ASN A 72 GLN A 75 GLU A 77 SITE 2 AC1 5 GLU A 80 SITE 1 AC2 18 GLU A 97 THR A 98 PHE A 174 ASP A 189 SITE 2 AC2 18 ALA A 190 CYS A 191 GLN A 192 SER A 195 SITE 3 AC2 18 VAL A 213 TRP A 215 GLY A 216 GLU A 217 SITE 4 AC2 18 GLY A 218 CYS A 220 ARG A 222 GLY A 226 SITE 5 AC2 18 ILE A 227 TYR A 228 CRYST1 72.290 78.040 56.630 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013833 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012814 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017658 0.00000